Suchergebnisse - "Xue, Xin"

PubPharm (8)

1

T cell cytotoxicity toward hematologic malignancy via B7-H3 targeting

enthalten in: Investigational new drugs | 2020

von Sun, X. | Yu, Y. | Ma, L. | +4

2

T cell cytotoxicity toward hematologic malignancy via B7-H3 targeting

enthalten in: Investigational new drugs | 2019

von Sun, X. | Yu, Y. | Ma, L. | +4

3

T cell cytotoxicity toward hematologic malignancy via B7-H3 targeting

enthalten in: Investigational new drugs | 2019

von Sun, X. | Yu, Y. | Ma, L. | +4

4

T cell cytotoxicity toward hematologic malignancy via B7-H3 targeting

enthalten in: Investigational new drugs | 2019

von Sun, X. | Yu, Y. | Ma, L. | +4

5

Schedule-dependent inhibition of T-cell lymphoma cells by cotreatment with the mTOR inhibitor everolimus and anticancer drugs

enthalten in: Investigational new drugs | 2012

von Huang, J. | Li, Z. | Huang, Y. | +5

6

Schedule-dependent inhibition of T-cell lymphoma cells by cotreatment with the mTOR inhibitor everolimus and anticancer drugs

enthalten in: Investigational new drugs | 2010

von Huang, J. | Li, Z. | Huang, Y. | +5

7

Schedule-dependent inhibition of T-cell lymphoma cells by cotreatment with the mTOR inhibitor everolimus and anticancer drugs

enthalten in: Investigational new drugs | 2010

von Huang, J. | Li, Z. | Huang, Y. | +5

8

Schedule-dependent inhibition of T-cell lymphoma cells by cotreatment with the mTOR inhibitor everolimus and anticancer drugs

enthalten in: Investigational new drugs | 2010

von Huang, J. | Li, Z. | Huang, Y. | +5

1
[1]